Skip to main content
Premium Trial:

Request an Annual Quote

EraGen Wins $100K NIH Grant to Develop Bioterror Tests

NEW YORK, Aug. 27 - EraGen Biosciences said it has been awarded a $100,000 grant from the US National Institutes of Health to develop tests to detect single copies of certain bioweapon agents.

 

EraGen said it will use its GeneCode technology to test for the existence of so-called Category A organisms, like Bacillus anthracis. R&D work on the tests began earlier this month and will continue for two years, the company said.

 

Click here for more information.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.